Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells

13 Feb 2023

Abstract excerpt

Mitophagy regulates cancer stem cell (CSC) populations affecting tumorigenicity and malignancy in various cancer types. Here, we report that cisplatin treatment led to the activation of higher mitophagy through regulating CLU (clusterin) levels in oral CSCs. Moreover, both the gain-of-function and loss-of-function of CLU indicated its mitophagy-specific role in clearing damaged mitochondria. CLU also regulates...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis
Share to FOXO transcription factor regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36779631
DOI: 10.1080/15548627.2023.2178876

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cellsPMID 36779631Read ↗

Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: Novel mechanism for anti‐cancer stem cell‐targeted cancer therapySemantic proximity Read ↗

Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapySemantic proximity Read ↗

Mitochondrial Damage Mediated by miR-1 Overexpression in Cancer Stem CellsSemantic proximity Read ↗

Ellagic Acid Induces DNA Damage and Apoptosis in Cancer Stem-like Cells and Overcomes Cisplatin ResistanceSemantic proximity Read ↗

Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancerSemantic proximity Read ↗

Cancer stem cells: mitochondria signalling pathway and strategies for therapeutic interventionsSemantic proximity Read ↗

MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.Semantic proximity Read ↗

Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potentialSemantic proximity Read ↗

New insights into mitophagy and stem cellsSemantic proximity Read ↗

The mitochondrial fission factor FIS1 promotes stemness of human lung cancer stem cells via mitophagySemantic proximity Read ↗

OMA1 maintains the stemness of glioma stem cells by inducing mitochondrial fission/fusion imbalanceSemantic proximity Read ↗

Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.